Drugs / Langenlianqiao
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06355193 | Nov → Dec 2022 | — | Central South University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Langenlianqiao | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06355193 ↗ |
| Known as | LGLQ | “langenlianqiao(LGLQ) treatment group” NCT06355193 ↗ |